Home>Topics>Stocks>Auxilium Pharmaceuticals

Auxilium Pharmaceuticals AUXL

  1. All
  2. Commentary
  3. Headlines
    1. PDUFA date approaches for Xiaflex label expansion

      Headlines

      Tue, 14 Oct 2014

      The FDA's PDUFA date for reviewing Auxilium Pharmaceuticals ' ( AUXL +1.9% ) sBLA requesting approval of Xiaflex (collagenase clostridium histolyticum) for the treatment of two Dupuytren's

    2. Lipocine TRT candidate successful in feasibility trial

      Headlines

      Mon, 13 Oct 2014

      respectively. The typical target for regulatory approval is 75%. A Phase 2b is expected to begin in Q1 2015. TRT-related tickers: (NASDAQ: RPRX ) (NYSE: LLY ) (NYSE: ABBV ) (NASDAQ: AUXL ) (NYSE: TEVA ) Post your comment!

    3. Premarket Gainers / Losers

      Headlines

      Thu, 9 Oct 2014

      Gainers: RT +16% . GTIV +15% . AUXL +12% . STV +8% . SNSS +6% . UAL +5% . Losers: KFX -23% . GPS -11% . AMD -8% . [[HUB-B]] -7% . ALU -7% . PT -6% . Post your comment!

    4. QLT Loses Merger Opportunity on Endo's Acquisition of Auxilium

      Commentary

      Thu, 9 Oct 2014

      Auxilium Pharmaceuticals , following its announced acquisition by Endo Pharmaceuticals, has terminated its planned merger with QLT, which will receive a $28

    5. Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal

      Headlines

      Thu, 9 Oct 2014

      Oct 9 (Reuters) - Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt.

    6. Auxilium agrees to sale to Endo for $2.6B

      Headlines

      Thu, 9 Oct 2014

      for each share of Auxilium (NASDAQ: AUXL ) vs. last night's close of $29.76, and represents a 55% premium to AUXL 's closing price on Sept. 16, the ..... 0.488 ENDP shares for each share of AUXL ), or all cash, or an equal mix of

    7. QLT Left At The Altar

      Headlines

      Wed, 1 Oct 2014

      M&A partners should be extremely careful. In the case of QLT Inc. (NASDAQ: QLTI ), its deal with Auxilium (NASDAQ: AUXL ) was never meant to be. QLT is a biotech company in Vancouver, Canada that focuses on developing products to treat retinal

    8. Recro Pharma: An Overlooked Opportunity With Disproportionate Risk/Reward

      Headlines

      Tue, 30 Sep 2014

      pharma company run by Gerri Henwood, one of the co-founders of AUXL . (The company ENDP is trying to buy for $2.2bn) The stock ..... cash, therefore we are obviously not talking about the next AUXL just yet. However, the stock sets up very nicely for risk tolerant

    9. LPCN 1021 hits primary endpoint in Phase 3 trial

      Headlines

      Wed, 24 Sep 2014

      elimination of the risk of inadvertent testosterone transfer associated with transdermal gels (before the gel dries). Related tickers: ( LLY +0.6% )( ABBV +1.1% )( RPRX +8.1% )( AUXL -0.2% )( TEVA +0.4% ) Post your comment!

    10. Auxilium says Endo offer a bit light but is willing to talk

      Headlines

      Mon, 22 Sep 2014

      Auxilium Pharmaceuticals ' ( AUXL -0.3% ) BOD says that Endo International's ( ENDP -1.7 ..... discussions with Endo. ENDP says that it is willing to work with AUXL on a deal. A marriage with Endo would probably scupper Auxilium

    « Prev12345Next »
    Content Partners